News

Asymmetric synthesis is a method for preparation of chemical compounds which aims to bias the synthesis in favour of producing one stereoisomer over another stereoisomer. Stereoisomers are ...
It is one of three major Novartis products that are nearing the end of their patent lives, along with cancer drug Tasigna (nilotinib) and Promacta (eltrombopag) for thrombocytopaenia, which ...
Novartis revealed this morning that it has decided to trim back its R&D pipeline by around 10% to 136 projects, as it continues its transition into a pure-play innovative medicines company.
A general method for the intermolecular coupling of aryl halides and amides using a Xantphos/Pd catalyst is described. This system displays good functional group compatibility, and the desired C−N ...